Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.
about
Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinomaUpdate on the management of cholangiocarcinoma.miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy--Long-Term Outcome of a Phase II Pilot Study.Therapeutic Potential of Adjuvant Stereotactic Body Radiotherapy for Gallbladder CancerAntitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cellsExtensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic CholangiocarcinomaA novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinomaPromoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma.Advances in the management of biliary tract cancersHaem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice.Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance.The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma.Curative resection of hilar cholangiocarcinoma in a 25-year-old woman: report of a case.Liver transplantation for hilar cholangiocarcinoma--a single-centre experience.Surgical management trends for cholangiocarcinoma in the USA 1998-2009.Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.Adjuvant chemotherapy in resectable cholangiocarcinoma patients.Reproductive factors and risk of biliary tract cancer in a population-based study.Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications.High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma.Hedgehog pathway as a potential treatment target in human cholangiocarcinoma.Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival.Incidence and mortality trends for biliary tract cancers in Austria.Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma
P2860
Q28080850-F27B8751-90D8-45A9-BF93-F555D86BF92CQ33656860-26EC5242-4092-41D1-AD56-6AAFA7E03901Q33813109-D10892C3-773E-4E4A-9BCF-DD937716090FQ34153255-4D512360-5781-4DD1-AE16-9150B2A75BCCQ35023269-6209738C-93DD-4890-BC88-E7ADBAF0B5A6Q35051799-4C745376-3343-40A7-898E-E3F4BA57ED70Q35839645-40C18A9A-E0DA-4C3C-84C4-C3478867C2C2Q36067376-97ADE96A-3B6C-43CF-8260-9DB64CD67153Q36094595-23C993B7-9BAB-4D1F-858C-F32A050B7CBCQ36592123-E6B8685C-3909-4A9A-821B-EEED0867725BQ36848730-B6CB9977-DF31-46D0-920B-26602671FF4EQ37497846-806E56D3-8F8C-4BE5-80D2-08B20F435C01Q37619847-EB9F7569-AF96-423D-BE67-61C2C527A24CQ38082318-2E2736A8-A7F1-44BA-8112-CAA5C389B5B6Q38806847-33F28AC3-D6A7-48E3-A2AF-1F95C591B0EFQ39114639-E81ECC26-B3C4-40D5-8090-4DA5BACAEDD6Q42225304-86793151-5781-442A-9641-85CFEBD7BF82Q42371588-8CD35E6A-119A-4D96-96B2-99441524A1BFQ44692031-056A93F3-C34C-4B54-96B0-D70776D2EB1DQ44785186-4A64C966-1D0F-4089-BDF6-11E0BA849AB8Q46034252-E36868EC-489D-44F4-906D-415FC13904CFQ47723879-C636A110-E808-41AF-A8E3-9C969A5BAF0DQ50795703-63BC5BAD-0B9C-4302-A082-B7DA560D8E04Q51047196-58FBB91D-28CA-4E66-BCA9-2E3B91D7D57FQ51187423-14B39449-06B6-4433-92C7-1B16A6F7F0D8Q51685400-B3C83924-B47F-4F38-AFA3-416E0CE903D4Q52858939-2AE2E156-CE43-490E-9103-FDA91CA012DBQ52877592-7647408E-F440-4EB6-9FB1-33E4B9CE6817Q54210722-A6C3C95D-94C9-41A6-8279-FE546886EEC7Q54774218-48FB7DB0-4E46-4D15-BC79-F889923DEC54Q57111846-FE343A43-5D87-4865-B1FD-2457EFD3E16F
P2860
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Review article: surgical, neo- ...... egies in biliary tract cancer.
@ast
Review article: surgical, neo- ...... egies in biliary tract cancer.
@en
type
label
Review article: surgical, neo- ...... egies in biliary tract cancer.
@ast
Review article: surgical, neo- ...... egies in biliary tract cancer.
@en
prefLabel
Review article: surgical, neo- ...... egies in biliary tract cancer.
@ast
Review article: surgical, neo- ...... egies in biliary tract cancer.
@en
P2093
P2860
P1476
Review article: surgical, neo- ...... tegies in biliary tract cancer
@en
P2093
J Bridgewater
J R A Skipworth
P2860
P304
P356
10.1111/J.1365-2036.2011.04851.X
P407
P577
2011-09-20T00:00:00Z